{
    "Trade/Device Name(s)": [
        "Synermed Glucose Reagent",
        "Synermed IR-1200 Chemistry Analyzer"
    ],
    "Submitter Information": "Infrared Laboratory Systems, LLC",
    "510(k) Number": "K153692",
    "Predicate Device Reference 510(k) Number(s)": [
        "K872494",
        "K903063"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "JJE"
    ],
    "Summary Letter Date": "June 20, 2016",
    "Summary Letter Received Date": "June 21, 2016",
    "Submission Date": "June 20, 2016",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.2160"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Discrete photometric chemistry analyzer for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Synermed IR-1200 Chemistry Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Spectrophotometric measurement",
        "Enzymatic (glucose oxidase) assay"
    ],
    "Methodologies": [
        "Endpoint",
        "Kinetic"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Synermed Glucose Reagent and Synermed IR-1200 Chemistry Analyzer for quantitative serum glucose measurement using spectrophotometry.",
    "Indications for Use Summary": "For in vitro quantitative measurement of glucose in serum on the Synermed IR-1200 Analyzer, aiding in diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and pancreatic islet cell carcinoma; analyzer intended for clinical laboratory use only.",
    "fda_folder": "Clinical Chemistry"
}